X0306 4 2020-11-18 0 0000081362 QUAKER CHEMICAL CORP KWR 0001659705 Hall Mary Dean ONE QUAKER PARK 901 E. HECTOR STREET CONSHOHOCKEN PA 19428 0 1 0 0 SVP, CFO and Treasurer Common Stock 2020-11-18 4 M 0 3838 72.12 A 9846 D Common Stock 2020-11-18 4 S 0 3873 253.73 D 5973 D Common Stock 2020-11-18 4 M 0 2445 134.60 A 8418 D Common Stock 2020-11-18 4 S 0 2167 255.05 D 6251 D Common Stock 2020-11-18 4 S 0 400 255.70 D 5851 D Common Stock 2020-11-18 4 S 0 1400 258.57 D 4451 D Common Stock 2020-11-18 4 S 0 387 259.25 D 4064 D Common Stock 2020-11-18 4 S 0 404 260.35 D 3660 D Common Stock 56 I By 401(k) Employee Stock Option (right to buy) 72.12 2020-11-18 4 M 0 3838 0.00 D 2023-02-23 Common Stock 3838 0 D Employee Stock Option (right to buy) 134.60 2020-11-18 4 M 0 2445 0.00 D 2024-02-27 Common Stock 2445 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $253.45 to $254.43, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $254.46 to $255.343, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $255.47 to $256.04, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $258.00 to $258.83, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $259.00 to $259.93, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (5) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $260.03 to $260.76, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (6) to this Form 4. Information based on reporting person's Plan Statement as of September 30, 2020. The options for this grant vested in three annual installments: 1,280 shares on February 23, 2017; 1,279 shares on February 23, 2018; and 1,279 shares on February 23, 2019. The options for this grant vested in three annual installments: 815 shares on February 27, 2018; 815 shares on February 27, 2019; and 815 shares on February 27, 2020. Victoria K. Gehris, Attorney-in-Fact for Mary Dean Hall 2020-11-20